Richard Harvey

Richard Harvey is a Lecturer in Molecular Pharmaceutics. His research is currently focused on studying molecular interactions between components of the bacterial cell envelope such as lipopolysaccharide and plasma membrane lipids, and membrane-active antimicrobial substances. To achieve this, his group uses a number of different experimental methods ranging from lipidomics and molecular spectroscopy to surface science techniques such as neutron reflectometry and diffraction. The overall aim of this work is to gain insight into physical mechanisms of drug tolerance in multi-resistant bacteria of clinical relevance, to aid the development of future anti-infectives. This research necessarily involves collaboration with infection control clinicians both within and beyond King’s Health Partners.